ECTRIMS 2019 at a glance

At ECTRIMS 2019, Biogen hosted many of you at our booth, in our business lounge, and at our satellite symposium, giving you the opportunity to discover the latest data and trends in the field of MS and management of MS patients.
 

Our satellite symposium is now live

In our symposium, our panel of speakers discussed the immunological insights of MS and their associated clinical considerations across the age span of MS.

The video of this symposium is now available for you to watch in your own time.

The choices you made at ECTRIMS 2019

Our booth activities at ECTRIMS 2019 aimed to highlight the MultiplefaceS of MS and the unique needs of every patient, as well as the MultiplepathS of the disease course and the resulting individuality of the treatment journey.

Our interactive survey was popular with congress attendees, who chose the patient factor that has the greatest impact on their treatment decisions. From most to least important, these factors were:

  • Risk1) Risk tolerance
  • Syringe2) Preferences regarding therapy
  • Women3) Family planning
  • Airplane4) Lifestyle
  • Comorbidities5) Comorbidities
  • Age6) Age

Our MS franchise key posters presented at ECTRIMS 2019

At ECTRIMS 2019, we presented several key posters on the latest advances in the field of MS, including quantitation of the disease course using metrics from the MS PATHS network, and non-clinical disease activity measures as markers for treatment response.

ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis;
MS PATHS: Multiple Sclerosis Partners Advancing Technology for Health Solutions.

Biogen-28276.
Date of preparation: October 2019.